Researchers ID receptor tied to neurodegenerative disease

08/26/2013 | Yahoo

A study in the journal Proceedings of the National Academy of Sciences suggests that obstructing the heparan sulfate proteoglycan receptor may offer hope for treating Alzheimer's, Parkinson's and other neurodegenerative disorders. Researchers genetically disabled HSPGs in mice and cell cultures, finding that clumps of tau protein were not able to penetrate cells, which prevented cell-to-cell spread of misfolded tau. The study also linked the receptors to the spread of alpha-synuclein protein, which is involved with Parkinson's disease.

View Full Article in:

Yahoo

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC